Search Results 1651-1660 of 19424 for hemoglobin

  1. Publications - Camille M. M. van Buskirk, M.D. - Mayo Clinic

    Jacob EK, Emery RL, Orrock JM, van Buskirk CM, Gandhi MJ. Filter failures with sickling hemoglobin. Transfusion. 2009 Aug; 49(8):1535-6. View PubMed.

  2. Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer - Mayo Clinic

    ... hemoglobin A1c (HbA1c) ≤ 8%; Negative serum pregnancy test ≤ 7 days prior to pre-registration for women of childbearing potential; Ability to understand and ...

  3. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

    - Hemoglobin ≥ 9.0 g/dL - Total and direct bilirubin within normal range - Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 3 x upper ...

  4. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. A Study Using Targeted Inhibitors to Treat Specific Tumor Mutations in Patients with Meningiomas - Mayo Clinic

    Uncontrolled diabetes defined as a known diabetic with hemoglobin A1C (HBA1C) > 7.5 OR fasting glucose > 140; Uncontrolled hypertension defined as blood ...

  6. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

    Hemoglobin > 10.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be ≤ ULN ...

  7. A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis - Mayo Clinic

    Adequate bone marrow reserve, defined as the following: absolute neutrophil count ≥1.0 × 109/L; platelet count ≥100 × 109/L; hemoglobin ≥10 g/dL;; Hepatic ...

  8. A Study to Evaluate Ipilimumab Administered Intra-lymphatically Using the Sofusa® DoseConnect™ DEVICE with IV-administered Nivolumab in Patients with Metastatic Melanoma - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 × ULN;; Alanine aminotransferase ...

  9. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL, independent of transfusion and/or growth factors (within 120 days prior to registration). Platelet count ≥ 100,000 x 10^9/uL ...

  10. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...